CJC-1295 with DAC and Teriparatide Interaction

Synergistic
Mechanism-based 47% confidence

CJC-1295 with DAC and Teriparatide have a synergistic interaction with 47% confidence. CJC-1295 with DAC and Teriparatide work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

Teriparatide

PTH(1-34) | Bone-Building Anabolic Peptide

Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity.

Half-life: ~1 hour (subcutaneous); ~5 minutes (intravenous) Typical dose: 20mcg daily (FDA-approved dose) healing
igf1pth receptor teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Blood Vessels
low

Frequently Asked Questions

Can I take CJC-1295 with DAC with Teriparatide?

Yes, CJC-1295 with DAC and Teriparatide can generally be taken together. CJC-1295 with DAC and Teriparatide work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 with DAC and Teriparatide safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between CJC-1295 with DAC and Teriparatide?

CJC-1295 with DAC and Teriparatide work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and Teriparatide?

CJC-1295 with DAC has a half-life of 6-8 days and Teriparatide has a half-life of ~1 hour (subcutaneous); ~5 minutes (intravenous). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs Teriparatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.